Medical therapies for hypercortisolism can be categorized into three groups based on their mechanism of action, including steroidogenesis inhibitors, neuromodulators of ACTH release, and glucocorticoid receptor-blocking agents. The gene discussed is NR3C1; the disease is adrenal gland hyperfunction.